If You Invested $10,000 in Bluebird Bio In 2021, This Is How Much You Would Have Today

It has been just over two years since Bluebird Bio (NASDAQ: BLUE) split into two separate companies. One focused on gene therapies and retained the Bluebird name; another focused on oncology, and now goes under the name 2seventy Bio. Below, I'll look at what your returns would look like if you…#bluebird #fda #lyfgenia #bluebirdbio #davidjagielski #motleyfool
Source: Reuters: Health - Category: Consumer Health News Source Type: news